Despite decades of research and thousands of studies on cardiac electrophysiology, cardiovascular disease remains among the leading causes of death in the United States today. Despite substantially beneficial advances, we have largely shifted cardiovascular disease from an acute to a chronic issue. It is therefore clear that our current understanding of the heart's functions remain inadequate and we must search for untapped therapeutic approaches to eliminate these deadly and costly ailments once and for all. This thesis will focus on the electrophysiology of the heart, specifically the mechanisms of cell-to-cell conduction. Canonically, the understood mechanism of cardiac conduction is through gap junctions (GJ) following a cable-like conduction model. While both experimentally and mathematically, this understanding of conduction has explained cardiac electrical behavior, it is also incomplete, as evidenced by recent conflicting modeling and experimental data. The overall goal of this thesis is to explore a structure modulating an ephaptic, or electric field, cellular coupling mechanism: the GJ-adjacent perinexus, with three specific aims. First, I identified the perinexus – a recently-established structure in rodent myocardium – in human atrial tissue. I also observed a significant tendency for open-heart surgery patients with pre-operative atrial fibrillation to have wider perinexi, indicating a possibly targetable mechanism of atrial fibrillation, one of the costliest, and most poorly-understood cardiac diseases. Next, I developed a high-throughput, high-resolution method for quantifying the perinexus. Finally, I sought to reconcile a major controversy in the field: whether cardiac edema could either be beneficial or harmful to cardiac conduction. Using a Langendorff perfusion model, I added osmotic agents of various sizes to guinea pig hearts and measured electrical and structural parameters. My findings suggest that while cardiac conduction is multifaceted and influenced by several parameters, the strongest correlation is an inverse relationship between conduction velocity and the width of the perinexus. This study is the first to osmotically expand and narrow the perinexus and show an inverse correlation with conduction. Importantly, my conduction data cannot be explained by factors consistent with a cable-like conduction mechanism, indicating once again that the perinexus could be a therapeutic target for a myriad of cardiac conduction diseases. / Doctor of Philosophy / The ways by which cells in the heart communicate have been studied extensively and are thought to be well-understood. However, despite decades of research, cardiovascular disease is a major problem in the developed world today and we remain unable to develop treatments to truly cure many major cardiac diseases. Because of this lack of clinical success in preventing or treating conditions such as atrial fibrillation, Brugada syndrome and sudden cardiac death, all of which are associated with disruptions in the heart’s electrical communication systems, I have sought to better understand the ways by which cellular communication is achieved. Currently, we think of cardiac tissue to propagate electrical signals as if it was a series of cables, just like the electrical wires over our streets and in our homes. However, we have seen experimental evidence, along with computer simulations, that supports the idea of a second mechanism of cellular electrical conduction. This second mechanism is called ephaptic, or electric field, coupling and relies on changes in charges inside and outside the cell to trigger the action potential – the electrical signal which tells the cell to contract. In order for ephaptic coupling to occur, two main conditions must be met. First, there must be a suitably-sized cleft, or ephapse, between adjacent cells. Models have estimated this space to be between 10-100 nm wide. Second, there must be a large concentration of sodium channels, as sodium ions are primarily used to set off the action potential. The region in which I am most interested is the cardiac perinexus, which is the space immediately adjacent to plaques of connexin proteins which link adjacent cells. The perinexus is both of an appropriate size (we’ve measured it between 10 and 25 nm on average) and rich in sodium channels, making it an ideal candidate to be a cardiac ephapse. In recent years, our lab has shown experimentally that expanding this space can disrupt cardiac conduction and my first study showed that clinically, patients with chronic atrial fibrillation (a-fib) prior to open-heart surgery have wider perinexi than patients without chronic a-fib. No one, however, has been able to demonstrate that narrowing the perinexus would be therapeutic by making it easier for cells to communicate via this ephaptic mechanism. Knowing I would need a better method for measuring the width of huge numbers of perinexi, I then developed a faster, more precise measurement program. Finally, I perfused several osmotic agents – substances which would theoretically draw fluid into or out of various compartments of cardiac tissue – into guinea pig hearts and observed changes to both their electrical behavior and tissue structure. Using my new perinexal measurement program, I found that changing the perinexus was the only factor that could explain the conduction changes I observed with each osmotic agent and that parameters associated with cable theory, such as gap junctional protein expression or interstitial resistance, could not explain conduction changes. Therefore, I have indicated, along with my clinical study, that the cardiac perinexus could be a therapeutic target for preventing, managing, or possibly even curing cardiac conduction diseases.

Sudden cardiac death is largely attributable to sudden onset ventricular arrhythmias. Alterations in cardiac conduction, particularly the slowing of conduction velocity is one major factor in arrhythmogenesis. By understanding the mechanisms and factors that modulate cardiac conduction velocity, we can assess and perhaps mitigate the risk of arrhythmia in patients for whom slowed conduction is a arrhythmogenic substrate. Cardiac conduction has traditionally been described by cable theory, which predicts an inverse relationship between extracellular resistance and conduction velocity (CV). However, in studies that reduce extracellular resistance by inducing interstitial edema, there are conflicting results, with some labs showing increased CV when edema is induced with one agent, and others showing reduced CV when edema is induced with a different agent. In the first part of this dissertation, we present experimental data in support of ephaptic coupling (EpC), a theorized mechanism of conduction that resolves these apparent contradictions. In the later part of this dissertation, we address how changes in sodium concentration can alter conduction, despite conventional wisdom suggesting that it should not. We show that when sodium channels are impaired, such as by genetic mutation or pharmacologic blockade, that conduction is sensitized to changes in sodium concentrations that would not otherwise induce changes in CV. We go on to explore the mechanisms that modulate this sensitivity and present data that show it is a function of both EpC and outward potassium currents. Taken together, these data expand our understanding of the mechanics behind cardiac conduction and demonstrate that EpC has a clinically relevant impact on conduction and represents a new pathway to explore in regard to the treatment and management of arrhythmogenic and conduction disorders. / Doctor of Philosophy / In all large animals, life is sustained by the regular coordinated beating of the heart to pump blood throughout the body. Throughout this continuous activity, and even with minute-to-minute changes in heart rate, this electrically driven activity continues without major disruption. Until it doesn't. Major arrhythmias can occur suddenly, and without warning. Over the last century, we have begun to understand some of the reasons why heart, even an injured one, will work normally for hundreds of thousands of beats, and on the next fall into a life-threatening new pattern, and one of the most important of these reasons is the speed of conduction: the spread of electrical activation throughout the heart tissue. Understanding the mechanisms of conduction provides a way to assess and mitigate the risk of arrhythmias and may open up new avenues for treatment and prevention. This dissertation presents evidence for a previously theoretical mechanism of conduction called ephaptic coupling. We show that this electric field mediated form of conduction can be modulated with clinically used osmotic agents, and that it has a physiologically relevant impact on conduction. We also show that hyponatremia (i.e. low sodium), a condition that is traditionally thought to have minimal impact on cardiac conduction, because a significant modulator of conduction when sodium channel functions are impaired. As a great many drugs block sodium channels, this sensitization to hyponatremia and the factors that mediate it are underappreciated concerns that are relevant to a wide array of patients. The new findings presented in this dissertation advance our collective understanding of the mechanisms of cardiac conduction and provide evidence for new avenues of exploration in the prevention and management of arrhythmias and conduction disorders.

Gain of function of cardiac voltage-gated sodium channel (Nav1.5) leads to Long QT Syndrome Type 3 (LQT3). LQT3 phenotype can be exacerbated by expanding the perinexus, which is an intercellular nanodomain with high density of Nav1.5 in the intercalated disc. Following this finding, we found that elevating extracellular sodium and widening the perinexus synergistically exacerbated LQT3 phenotype, Importantly, we also found that perinexal expansion increases the susceptibility to cardiac arrest in aged LQT3, which demonstrated that perinexal expansion is an arrhythmogenic risk especially in aged LQT3 patients. Furthermore, we observed that the perinexus narrows with aging and conceals LQT3 phenotype, which suggests that perinexal narrowing may have a cardio-protective role during aging in LQT3. Surprisingly, following the finding of the synergistic effect of extracellular sodium elevation and perinexal widening on LQT3 phenotype in drug-induced LQT3 guinea pig hearts, we found that this synergistic effect was not observed in genetically-modified LQT3 mouse hearts, which is due to high sodium also increasing transient outward potassium current (Ito). In summary, the whole project investigated the role of the perinexus in LQT3 from different conditions including sodium, aging and species. The findings in this project discovered the importance of perinexal expansion in LQT3 and also the involvement of Ito in sodium regulating LQT3 phenotype in hearts which functionally express Ito channels. Therefore, a LQT3 animal model which has similar electrophysiology close to human may be a great option for translational purpose. / Doctor of Philosophy / Long QT Syndrome Type 3 (LQT3) is an inherited heart disease with the phenotype of long QT interval in ECG. It has been found that LQT3 phenotype gets worse when a very tiny space in the heart, termed as the perinexus, is wide due to cardiac edema. Following this finding, we also found that increasing sodium concentration together with wide perinexus can further exacerbate LQT3 phenotype in guinea pig hearts. Furthermore, we found that widening the perinexus in aged LQT3 hearts causes cardiac death but not in adult, which suggests that perinexal widening worsens LQT3 phenotype and even leads to cardiac death in aged hearts. Besides, we found that the perinexus narrows with aging and there is no difference in LQT3 phenotype between adult and aged hearts, which suggests that the narrow perinexus during aging may protect the hearts from cardiac death in LQT3. Surprisingly, we discovered that increasing sodium and widening the perinexus together fails to exacerbate LQT3 phenotype when compared with widening the perinexus alone in LQT3 mouse hearts, which is due to high sodium increasing transient outward potassium current (Ito). Notably, Ito channels are not functionally expressed in guinea pig hearts. In summary, the whole project investigated the role of the perinexus in LQT3 from different conditions including sodium, aging and species. The findings in this project discovered the importance of perinexal expansion in LQT3 and also the involvement of Ito in sodium regulating LQT3 phenotype in hearts. Therefore, a LQT3 animal model which has similar electrophysiology close to human may be a great option for translational purpose.